A Mitochondria‐Targeted Flavokawain A Derivative Suppresses Lymphoma by Disrupting Oxidative Phosphorylation
ChemPlusChem · 2026-06 · 91 (6)
DOI: 10.1002/cplu.202500691 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemPlusChem, online erschienen am 14.06.2026. Verfasst von Shufang Fan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Health science center, Ningbo University, Ningbo, China. Hauptthemen laut MEDLINE: Mitochondria, Oxidative Phosphorylation, Antineoplastic Agents, Lymphoma, Large B-Cell, Diffuse. Die Arbeit nennt 38 Literaturangaben. Gefördert von: Zhejiang Provincial Traditional Chinese Medicine Science and Technology Project, Zhejiang Provincial Basic Public Welfare Research Project, Zhejiang Province Medicine Health Science and Technology Project.
Abstract (Originalsprache)
Diffuse large B‐cell lymphoma (DLBCL) remains clinically challenging because of drug resistance and relapse after standard therapy. In this study, we developed TPP‐FLA, a mitochondria‐targeted derivative of Flavokawain A (FLA) generated by conjugation with triphenylphosphonium (TPP), and evaluated its antilymphoma activity and underlying mechanism. Compared with FLA, TPP‐FLA showed markedly enhanced antiproliferative activity and induced stronger lymphoma cell death and apoptosis in multiple lymphoma cell lines. Mechanistically, TPP‐FLA caused pronounced mitochondrial dysfunction, as evidenced by mitochondrial membrane potential collapse detected by JC‐1 staining and independently validated by Tetramethylrhodamine Methyl Ester (TMRM) staining. TPP‐FLA also increased total intracellular oxidative stress, as detected by DCFH‐DA, and specifically promoted mitochondria‐derived superoxide accumulation, as confirmed by MitoSOX Red staining. Transcriptomic and DIA‐based proteomic analyses further revealed that TPP‐FLA significantly disrupted mitochondrial energy metabolism, particularly oxidative phosphorylation‐related pathways. Collectively, these findings demonstrate that TPP conjugation substantially enhances the antilymphoma activity of FLA by inducing mitochondrial depolarization, oxidative stress, and oxidative phosphorylation disruption. TPP‐FLA may therefore represent a promising mitochondria‐targeted candidate for lymphoma therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Health science center, Ningbo University, Ningbo, China.
- Department of Hematology, The First Affiliated Hospital of Ningbo University, Ningbo, China.
- Department of Hematology, Lianyungang Second People's Hospital, Lianyungang, China.
- Faculty of Materials Science and Chemical Engineering, Ningbo University, Ningbo, China.
ORCID-Profile: Jingbo Hu, Guifang Ouyang
Förderung
- Zhejiang Provincial Traditional Chinese Medicine Science and Technology Project
- Zhejiang Provincial Basic Public Welfare Research Project
- Zhejiang Province Medicine Health Science and Technology Project
Zitieren
APA
Fan, S., Zhuang, W., Ge, Q., Hu, J., & Ouyang, G. (2026). A Mitochondria‐Targeted Flavokawain A Derivative Suppresses Lymphoma by Disrupting Oxidative Phosphorylation. ChemPlusChem, 91(6). https://doi.org/10.1002/cplu.202500691
Vancouver
Fan S, Zhuang W, Ge Q, Hu J, Ouyang G. A Mitochondria‐Targeted Flavokawain A Derivative Suppresses Lymphoma by Disrupting Oxidative Phosphorylation. ChemPlusChem. 2026;91(6). doi:10.1002/cplu.202500691
BibTeX
@article{Fan2026,
author = {Fan, Shufang and Zhuang, Wanchuan and Ge, Qunfang and Hu, Jingbo and Ouyang, Guifang},
title = {A Mitochondria‐Targeted Flavokawain A Derivative Suppresses Lymphoma by Disrupting Oxidative Phosphorylation},
journal = {ChemPlusChem},
year = {2026},
volume = {91},
number = {6},
doi = {10.1002/cplu.202500691}
}
EUVIMED